Literature DB >> 14569048

Trends in waist circumference among U.S. adults.

Earl S Ford1, Ali H Mokdad, Wayne H Giles.   

Abstract

OBJECTIVE: Waist circumference has been proposed as a measure of obesity or as an adjunct to other anthropometric measures to determine obesity. Our objective was to examine temporal trends in waist circumference among adults in the U.S. RESEARCH METHODS AND PROCEDURES: We used data from 15,454 participants >/=20 years old in National Health and Nutrition Examination Survey (NHANES) III (1988 to 1994) and 4024 participants >/=20 years old from National Health and Nutrition Examination Survey 1999 to 2000.
RESULTS: The unadjusted waist circumference increased from 95.3 (age-adjusted, 96.0 cm) to 98.6 (age-adjusted, 98.9 cm) cm among men and from 88.7 (age-adjusted 88.9 cm) to 92.2 (age-adjusted 92.1 cm) cm among women. The percentiles from the two surveys suggest that much of the waist circumference distribution has shifted. Statistically significant increases occurred among all age groups and racial or ethnic groups except men 30 to 59 years old, women 40 to 59 and >/=70 years old, and women who were Mexican American or of "other" race or ethnicity. DISCUSSION: These results demonstrate the rapid increase in obesity, especially abdominal obesity, among U.S. adults. Unless measures are taken to slow the increase in or reverse the course of the obesity epidemic, the burden of obesity-associated morbidity and mortality in the U.S. can be expected to increase substantially in future years.

Entities:  

Mesh:

Year:  2003        PMID: 14569048     DOI: 10.1038/oby.2003.168

Source DB:  PubMed          Journal:  Obes Res        ISSN: 1071-7323


  78 in total

Review 1.  The global epidemic of obesity: are we becoming more sympathetic?

Authors:  Kevin P Davy
Journal:  Curr Hypertens Rep       Date:  2004-06       Impact factor: 5.369

Review 2.  The link between the renin-angiotensin-aldosterone system and renal injury in obesity and the metabolic syndrome.

Authors:  Tina Thethi; Masumi Kamiyama; Hiroyuki Kobori
Journal:  Curr Hypertens Rep       Date:  2012-04       Impact factor: 5.369

3.  Drug treatment for obesity in the post-sibutramine era.

Authors:  Bernard M Y Cheung
Journal:  Drug Saf       Date:  2011-08-01       Impact factor: 5.606

Review 4.  Adiposity and Alzheimer's disease.

Authors:  José A Luchsinger; Deborah R Gustafson
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2009-01       Impact factor: 4.294

5.  Pharmacotherapy for obesity.

Authors:  Mingfang Li; Bernard M Y Cheung
Journal:  Br J Clin Pharmacol       Date:  2009-12       Impact factor: 4.335

6.  Large artery stiffening with weight gain in humans: role of visceral fat accumulation.

Authors:  Jeb S Orr; Christopher L Gentile; Brenda M Davy; Kevin P Davy
Journal:  Hypertension       Date:  2008-05-05       Impact factor: 10.190

Review 7.  Adiposity, hyperinsulinemia, diabetes and Alzheimer's disease: an epidemiological perspective.

Authors:  José Alejandro Luchsinger
Journal:  Eur J Pharmacol       Date:  2008-03-04       Impact factor: 4.432

8.  Sex difference of type 2 diabetes affected by abdominal obesity versus overall obesity.

Authors:  Kyung-Won Paek; Ki-Hong Chun
Journal:  Yonsei Med J       Date:  2010-11       Impact factor: 2.759

9.  The 6th Annual World Congress on the insulin resistance syndrome.

Authors:  Zachary T Bloomgarden
Journal:  Diabetes Care       Date:  2009-09       Impact factor: 19.112

10.  Visceral obesity and the risk of Barrett's esophagus in Japanese patients with non-alcoholic fatty liver disease.

Authors:  Tomoyuki Akiyama; Masato Yoneda; Masahiko Inamori; Hiroshi Iida; Hiroki Endo; Kunihiro Hosono; Kyoko Yoneda; Koji Fujita; Tomoko Koide; Chikako Tokoro; Hirokazu Takahashi; Ayumu Goto; Yasunobu Abe; Hiroyuki Kirikoshi; Noritoshi Kobayashi; Kensuke Kubota; Satoru Saito; Atsushi Nakajima
Journal:  BMC Gastroenterol       Date:  2009-07-21       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.